Cronos Group (CRON) Competitors C$2.86 -0.01 (-0.35%) As of 10:56 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CRON vs. AUP, BHC, CARA, TEV, SLS, ABT, NOT, PYR, NVO, and DNAShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurinia Pharmaceuticals (AUP), Bausch Health Companies (BHC), Cara Operations (CARA), Tervita (TEV), Solaris Resources (SLS), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Aurinia Pharmaceuticals Bausch Health Companies Cara Operations Tervita Solaris Resources Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Dalradian Resources Cronos Group (TSE:CRON) and Aurinia Pharmaceuticals (TSE:AUP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability. Do institutionals and insiders believe in CRON or AUP? 16.0% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer CRON or AUP? Aurinia Pharmaceuticals received 178 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes6950.74% Underperform Votes6749.26% Aurinia PharmaceuticalsOutperform Votes24772.22% Underperform Votes9527.78% Does the media favor CRON or AUP? In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Aurinia Pharmaceuticals'average media sentiment score. Company Overall Sentiment Cronos Group Neutral Aurinia Pharmaceuticals Neutral Is CRON or AUP more profitable? Aurinia Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-42.65% -4.40% -3.73% Aurinia Pharmaceuticals N/A N/A N/A Which has better earnings & valuation, CRON or AUP? Cronos Group has higher revenue and earnings than Aurinia Pharmaceuticals. Cronos Group is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$76.86M9.83-C$32.78M-C$0.18-15.91Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A SummaryAurinia Pharmaceuticals beats Cronos Group on 6 of the 11 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$755.23MC$2.16BC$5.31BC$5.93BDividend YieldN/A2.92%5.21%6.33%P/E Ratio-15.913.9726.7829.95Price / Sales9.83526.91386.97825.01Price / Cash1.6710.2538.2583.71Price / Book0.976.896.743.96Net Income-C$32.78MC$20.70BC$3.23BC$301.69M7 Day Performance-2.05%-0.52%1.49%0.64%1 Month Performance16.73%4.73%11.47%7.29%1 Year Performance-24.74%89.76%16.57%15.72% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos GroupN/AC$2.86-0.3%N/A-24.5%C$755.23MC$76.86M-15.91450AUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading VolumeBHCBausch Health CompaniesN/AC$6.51-2.7%N/A-30.4%C$1.69BC$6.69B-9.5319,900Gap UpCARACara OperationsN/AN/AN/AN/AC$1.62BN/A0.0080TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpSLSSolaris Resources1.7525 of 5 starsC$5.67-3.1%C$13.90+145.1%+11.6%C$650.43MN/A-9.8810News CoverageGap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640 Related Companies and Tools Related Companies Aurinia Pharmaceuticals Alternatives Bausch Health Companies Alternatives Cara Operations Alternatives Tervita Alternatives Solaris Resources Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Dalradian Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRON Stock Free CRON Stock Alerts